Orchestra BioMed Holdings Inc’s filing revealed that its Director Fain Eric S acquired Company’s shares for reported $15034.0 on Aug 25 ’25. In the deal valued at $2.61 per share,5,760 shares were bought. As a result of this transaction, Fain Eric S now holds 71,709 shares worth roughly $0.22 million.
Then, Sherman Darren bought 3,000 shares, generating $7,860 in total proceeds. Upon buying the shares at $2.62, the insider now owns 926,837 shares.
Before that, Hochman David P bought 6,000 shares. Orchestra BioMed Holdings Inc shares valued at $14,940 were divested by the insider at a price of $2.49 per share. As a result of the transaction, Hochman David P now holds 651,460 shares, worth roughly $1.95 million.
BTIG Research downgraded its Orchestra BioMed Holdings Inc [OBIO] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including BTIG Research’s analysts, who began to cover the stock in mid March with a ‘”a Buy”‘ rating. Barclays began covering OBIO with “an Overweight” recommendation on January 02, 2025. H.C. Wainwright started covering the stock on August 22, 2024. It rated OBIO as “a Buy”.
Price Performance Review of OBIO
On Tuesday, Orchestra BioMed Holdings Inc [NASDAQ:OBIO] saw its stock jump 15.38% to $3.0. Over the last five days, the stock has gained 17.65%. Orchestra BioMed Holdings Inc shares have fallen nearly -51.46% since the year began. Nevertheless, the stocks have fallen -25.00% over the past one year. While a 52-week high of $7.04 was reached on 01/02/25, a 52-week low of $2.37 was recorded on 05/07/25.
Levels Of Support And Resistance For OBIO Stock
The 24-hour chart illustrates a support level at 2.73, which if violated will result in even more drops to 2.46. On the upside, there is a resistance level at 3.17. A further resistance level may holdings at 3.35.
How much short interest is there in Orchestra BioMed Holdings Inc?
A steep rise in short interest was recorded in Orchestra BioMed Holdings Inc stocks on 2025-08-15, growing by 5302.0 shares to a total of 0.56 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 0.56 million shares. There was a rise of 0.94%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 25, 2024 when B. Riley Securities began covering the stock and recommended ‘”a Buy”‘ rating along with a $15 price target.
